High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever

Implications for pathogenesis

Wei Kung Wang, Day Yu Chao, Chuan Liang Kao, Han Chung Wu, Yung Ching Liu, Chien Ming Li, Shih Chung Lin, Shih Ting Ho, Jyh Hsiung Huang, Chwan Chuen King

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Studies of the pathogenesis of dengue hemorrhagic fever (DHF), a potentially life-threatening disease, have revealed the importance of initial high levels of virus replication. However, the possible involvement of virus during the transition from fever to defervescence, a critical stage in determining the severity of disease, has not been appreciated. Using quantitative reverse transcription-polymerase chain reaction, we examined the levels of plasma dengue viral load during both fever and defervescence periods in patients from a DEN-3 outbreak in southern Taiwan in 1998. Higher levels of plasma dengue viral RNA were found in DHF patients than in DF patients. During defervescence, while the level of plasma dengue viral RNA was undetectable in most DF patients, it remains high in all DHF patients. Using a modified immunoprecipitation assay, we demonstrated for the first time that the plasma dengue viruses persisting during defervescence were in the immune complexes for most DHF patients. These findings suggest that continued active viral replication or delay in the clearance of viremia contributes to the pathogenesis of DHF. Moreover, high levels of plasma dengue viral RNA during defervescence may serve as a disease marker for DHF.

Original languageEnglish
Pages (from-to)330-338
Number of pages9
JournalVirology
Volume305
Issue number2
DOIs
Publication statusPublished - Jan 20 2003
Externally publishedYes

Fingerprint

Severe Dengue
Dengue
Viral Load
Viral RNA
Fever
Dengue Virus
Viremia
Virus Replication
Antigen-Antibody Complex
Taiwan
Immunoprecipitation
Reverse Transcription
Disease Outbreaks
Viruses
Polymerase Chain Reaction

Keywords

  • Dengue virus
  • Immune complex
  • Pathogenesis
  • Quantification
  • RT-PCR

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever : Implications for pathogenesis. / Wang, Wei Kung; Chao, Day Yu; Kao, Chuan Liang; Wu, Han Chung; Liu, Yung Ching; Li, Chien Ming; Lin, Shih Chung; Ho, Shih Ting; Huang, Jyh Hsiung; King, Chwan Chuen.

In: Virology, Vol. 305, No. 2, 20.01.2003, p. 330-338.

Research output: Contribution to journalArticle

Wang, Wei Kung ; Chao, Day Yu ; Kao, Chuan Liang ; Wu, Han Chung ; Liu, Yung Ching ; Li, Chien Ming ; Lin, Shih Chung ; Ho, Shih Ting ; Huang, Jyh Hsiung ; King, Chwan Chuen. / High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever : Implications for pathogenesis. In: Virology. 2003 ; Vol. 305, No. 2. pp. 330-338.
@article{17dc810ef04647cfa0a977939a4aa046,
title = "High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: Implications for pathogenesis",
abstract = "Studies of the pathogenesis of dengue hemorrhagic fever (DHF), a potentially life-threatening disease, have revealed the importance of initial high levels of virus replication. However, the possible involvement of virus during the transition from fever to defervescence, a critical stage in determining the severity of disease, has not been appreciated. Using quantitative reverse transcription-polymerase chain reaction, we examined the levels of plasma dengue viral load during both fever and defervescence periods in patients from a DEN-3 outbreak in southern Taiwan in 1998. Higher levels of plasma dengue viral RNA were found in DHF patients than in DF patients. During defervescence, while the level of plasma dengue viral RNA was undetectable in most DF patients, it remains high in all DHF patients. Using a modified immunoprecipitation assay, we demonstrated for the first time that the plasma dengue viruses persisting during defervescence were in the immune complexes for most DHF patients. These findings suggest that continued active viral replication or delay in the clearance of viremia contributes to the pathogenesis of DHF. Moreover, high levels of plasma dengue viral RNA during defervescence may serve as a disease marker for DHF.",
keywords = "Dengue virus, Immune complex, Pathogenesis, Quantification, RT-PCR",
author = "Wang, {Wei Kung} and Chao, {Day Yu} and Kao, {Chuan Liang} and Wu, {Han Chung} and Liu, {Yung Ching} and Li, {Chien Ming} and Lin, {Shih Chung} and Ho, {Shih Ting} and Huang, {Jyh Hsiung} and King, {Chwan Chuen}",
year = "2003",
month = "1",
day = "20",
doi = "10.1006/viro.2002.1704",
language = "English",
volume = "305",
pages = "330--338",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever

T2 - Implications for pathogenesis

AU - Wang, Wei Kung

AU - Chao, Day Yu

AU - Kao, Chuan Liang

AU - Wu, Han Chung

AU - Liu, Yung Ching

AU - Li, Chien Ming

AU - Lin, Shih Chung

AU - Ho, Shih Ting

AU - Huang, Jyh Hsiung

AU - King, Chwan Chuen

PY - 2003/1/20

Y1 - 2003/1/20

N2 - Studies of the pathogenesis of dengue hemorrhagic fever (DHF), a potentially life-threatening disease, have revealed the importance of initial high levels of virus replication. However, the possible involvement of virus during the transition from fever to defervescence, a critical stage in determining the severity of disease, has not been appreciated. Using quantitative reverse transcription-polymerase chain reaction, we examined the levels of plasma dengue viral load during both fever and defervescence periods in patients from a DEN-3 outbreak in southern Taiwan in 1998. Higher levels of plasma dengue viral RNA were found in DHF patients than in DF patients. During defervescence, while the level of plasma dengue viral RNA was undetectable in most DF patients, it remains high in all DHF patients. Using a modified immunoprecipitation assay, we demonstrated for the first time that the plasma dengue viruses persisting during defervescence were in the immune complexes for most DHF patients. These findings suggest that continued active viral replication or delay in the clearance of viremia contributes to the pathogenesis of DHF. Moreover, high levels of plasma dengue viral RNA during defervescence may serve as a disease marker for DHF.

AB - Studies of the pathogenesis of dengue hemorrhagic fever (DHF), a potentially life-threatening disease, have revealed the importance of initial high levels of virus replication. However, the possible involvement of virus during the transition from fever to defervescence, a critical stage in determining the severity of disease, has not been appreciated. Using quantitative reverse transcription-polymerase chain reaction, we examined the levels of plasma dengue viral load during both fever and defervescence periods in patients from a DEN-3 outbreak in southern Taiwan in 1998. Higher levels of plasma dengue viral RNA were found in DHF patients than in DF patients. During defervescence, while the level of plasma dengue viral RNA was undetectable in most DF patients, it remains high in all DHF patients. Using a modified immunoprecipitation assay, we demonstrated for the first time that the plasma dengue viruses persisting during defervescence were in the immune complexes for most DHF patients. These findings suggest that continued active viral replication or delay in the clearance of viremia contributes to the pathogenesis of DHF. Moreover, high levels of plasma dengue viral RNA during defervescence may serve as a disease marker for DHF.

KW - Dengue virus

KW - Immune complex

KW - Pathogenesis

KW - Quantification

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=0037455555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037455555&partnerID=8YFLogxK

U2 - 10.1006/viro.2002.1704

DO - 10.1006/viro.2002.1704

M3 - Article

VL - 305

SP - 330

EP - 338

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -